Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
500.19
-0.96 (-0.19%)
At close: May 5, 2025, 4:00 PM
485.00
-15.19 (-3.04%)
After-hours: May 5, 2025, 4:35 PM EDT

Vertex Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
11,09011,0209,8698,9317,5736,203
Upgrade
Other Revenue
10---12.9
Upgrade
Revenue
11,10011,0209,8698,9317,5746,206
Upgrade
Revenue Growth (YoY)
8.98%11.66%10.51%17.91%22.06%49.08%
Upgrade
Cost of Revenue
5,0164,9964,4253,6082,8422,381
Upgrade
Gross Profit
6,0846,0245,4445,3234,7323,825
Upgrade
Selling, General & Admin
1,4851,4321,137944.7840.1770.5
Upgrade
Operating Expenses
1,6761,4321,137944.7840.1770.5
Upgrade
Operating Income
4,4084,5934,3084,3783,8923,054
Upgrade
Interest Expense
-23.2-30.6-44.1-54.8-61.5-58.2
Upgrade
Interest & Investment Income
537.8598.1614.7144.64.922.2
Upgrade
Currency Exchange Gain (Loss)
-27.3-27.3-24.6-15.1-13.9-16.1
Upgrade
Other Non Operating Income (Expenses)
-35.7-49.39.3-0.61.70.8
Upgrade
EBT Excluding Unusual Items
4,8595,0844,8634,4533,8243,003
Upgrade
Merger & Restructuring Charges
-197.6-197.6----
Upgrade
Gain (Loss) on Sale of Investments
-9.5-9.5-7.5-149.117.1311.9
Upgrade
Asset Writedown
-379---13--
Upgrade
Other Unusual Items
-1.80.551.657.53.1-13.1
Upgrade
Pretax Income
-300.2248.54,3804,2322,7303,117
Upgrade
Income Tax Expense
688.7784.1760.2910.4388.3405.2
Upgrade
Earnings From Continuing Operations
-988.9-535.63,6203,3222,3422,712
Upgrade
Net Income to Company
-988.9-535.63,6203,3222,3422,712
Upgrade
Net Income
-988.9-535.63,6203,3222,3422,712
Upgrade
Net Income to Common
-988.9-535.63,6203,3222,3422,712
Upgrade
Net Income Growth
--8.96%41.84%-13.63%130.43%
Upgrade
Shares Outstanding (Basic)
258258258256258260
Upgrade
Shares Outstanding (Diluted)
258258261259260263
Upgrade
Shares Change (YoY)
-1.20%-1.00%0.54%-0.31%-1.33%1.04%
Upgrade
EPS (Basic)
-3.84-2.0814.0512.979.0910.44
Upgrade
EPS (Diluted)
-3.84-2.0813.8912.829.0110.29
Upgrade
EPS Growth
--8.35%42.29%-12.44%128.16%
Upgrade
Free Cash Flow
--790.33,3373,9252,4092,994
Upgrade
Free Cash Flow Per Share
--3.0612.8115.159.2711.37
Upgrade
Gross Margin
54.81%54.67%55.16%59.60%62.48%61.63%
Upgrade
Operating Margin
39.71%41.68%43.65%49.03%51.39%49.21%
Upgrade
Profit Margin
-8.91%-4.86%36.68%37.20%30.92%43.70%
Upgrade
Free Cash Flow Margin
--7.17%33.81%43.95%31.80%48.24%
Upgrade
EBITDA
4,5824,7754,4774,5274,0183,164
Upgrade
EBITDA Margin
41.28%43.33%45.36%50.69%53.05%50.98%
Upgrade
D&A For EBITDA
174182169.5148.3125.6109.5
Upgrade
EBIT
4,4084,5934,3084,3783,8923,054
Upgrade
EBIT Margin
39.71%41.68%43.65%49.03%51.39%49.21%
Upgrade
Effective Tax Rate
-315.53%17.36%21.51%14.22%13.00%
Upgrade
Revenue as Reported
79.6---7,5746,206
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q